PSIWM
DARE icon

Paradigm Strategies in Wealth Management’s Dare Bioscience DARE Stock Holding History

Paradigm Strategies in Wealth Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,863
Closed -$45K – 47
2021
Q4 		$45K Sell
1,863
-62
-3% -$1.27K 0.05% 50
2021
Q3 		$39K Buy
1,925
+1,092
+131% +$21.5K 0.04% 49
2021
Q2 		$19K Buy
+833
New +$14.2K 0.02% 138

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Paradigm Strategies in Wealth Management's DARE Position: Q1 2022 in Review

Paradigm Strategies in Wealth Management sold out of Dare Bioscience (DARE) in Q1 2022, closing a stake of 1,863 shares — an estimated $45K sold.

Paradigm Strategies in Wealth Management first reported a position in DARE in Q2 2021 and held it in 3 quarters. The position peaked at $45K in Q4 2021. 40 funds tracked by Wall St. Rank hold DARE as of Q1 2022.

  • Paradigm Strategies in Wealth Management reported no remaining Dare Bioscience position as of Q1 2022 after selling out during the quarter.
  • Paradigm Strategies in Wealth Management sold 1,863 Dare Bioscience shares in Q1 2022, an estimated $45K.
  • Paradigm Strategies in Wealth Management first reported a position in Dare Bioscience in Q2 2021 and held it in 3 quarters.
  • Paradigm Strategies in Wealth Management's Dare Bioscience position peaked at $45K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2022.

Based on Paradigm Strategies in Wealth Management's 13F filing for Q1 2022, filed 18 Apr 2022.